FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Richman

Research Profile

Chemicals & Drugs

Disorders

Activities & Behaviors

Drug Evaluation

Procedures

Phenomena

Spontaneous Remission

Concepts & Ideas

Survival Rate

Co-author Network

Publications

TOP 3
Charles S Cleeland; Kai-Ping Liao; Garrett R Lynch; Tito R Mendoza; Gary M Mobley; Arlene Nazario; Guadalupe R Palos; Stephen Richman; Xin Shelley Wang; Jeanie F Woodruff; Charles Lu
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center.
Christopher Lobo; LOPES GILBERTO; Odalys Baez; Aurelio Castrellon; Annapoorna Ferrell; Connie Higgins; Erin Hurley; Judith Hurley; Isildinha M Reis; Stephen Richman; Pearl Seo; Orlando Silva; Joyce M Slingerland; Keleni Tukia; Catherine Welsh; Stefan Gluck
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
Karen O Anderson; Tito R Mendoza; Richard Payne; Vicente Valero; Guadalupe R Palos; Arlene Nazario; Stephen Richman; Judith Hurley DeLeo; Ibrahima Gning; Garrett R Lynch; Dorianne Kalish; Charles S Cleeland
Pain education for underserved minority cancer patients: a randomized controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Richman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Charles S Cleeland; Kai-Ping Liao; Garrett R Lynch; Tito R Mendoza; Gary M Mobley; Arlene Nazario; Guadalupe R Palos; Stephen Richman; Xin Shelley Wang; Jeanie F Woodruff; Charles Lu
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(21):2859-65.
2010: Christopher Lobo; LOPES GILBERTO; Odalys Baez; Aurelio Castrellon; Annapoorna Ferrell; Connie Higgins; Erin Hurley; Judith Hurley; Isildinha M Reis; Stephen Richman; Pearl Seo; Orlando Silva; Joyce M Slingerland; Keleni Tukia; Catherine Welsh; Stefan Gluck
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
Breast cancer research and treatment 2010;123(2):427-35.
2004: Karen O Anderson; Tito R Mendoza; Richard Payne; Vicente Valero; Guadalupe R Palos; Arlene Nazario; Stephen Richman; Judith Hurley DeLeo; Ibrahima Gning; Garrett R Lynch; Dorianne Kalish; Charles S Cleeland
Pain education for underserved minority cancer patients: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4918-25.
2002: Karen O Anderson; Stephen Richman; Judith Hurley DeLeo; Guadalupe R Palos; Vicente Valero; Tito R Mendoza; Ibrahima Gning; Charles S Cleeland
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control.
Cancer 2002;94(8):2295-304.
2000: Karen O Anderson; Tito R Mendoza; Vicente Valero; Stephen Richman; C Russell; Judith Hurley DeLeo; C DeLeon; P Washington; Guadalupe R Palos; Richard Payne; Charles S Cleeland
Minority cancer patients and their providers: pain management attitudes and practice.
Cancer 2000;88(8):1929-38.
1998: L E Morrell; Y J Lee; Judith Hurley DeLeo; M Arias; C Mies; Stephen Richman; H Fernandez; K A Donofrio; William A Raub; Peter A Cassileth
A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma.
Cancer 1998;82(3):503-11.
1996: R L Martino; T R Fleming; L M Morrell; Bach Ardalan; Stephen Richman; J S Macdonald
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group study.
Investigational new drugs 1996;14(4):419-21.
1995: Robert P Whitehead; M K Wolf; D L Solanki; G P Hemstreet; Pasquale Benedetto; Stephen Richman; R C Flanigan; E D Crawford
A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(2):104-14.
1995: Lynn Feun; Niramol Savaraj; Frederick L Moffat; D Robinson; A Liebmann; Judith Hurley DeLeo; W A Raub; Stephen Richman
Phase II trial of recombinant interferon-alpha with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma.
Melanoma research 1995;5(4):273-6.
1994: Bach Ardalan; A Ucar; R Reddy; Alan Livingstone; Arnold Markoe; J Schwade; Stephen Richman; K Donofrio
Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
Cancer 1994;74(7):1869-73.
1994: A Hantel; C M Tangen; J S Macdonald; Stephen Richman; R P Pugh; T Pollock
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.
Investigational new drugs 1994;12(2):155-7.
1993: Sarah A Taylor; J Benedetti; D Schuller; Stephen Richman; G O Broun; A Hantel
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.
Investigational new drugs 1993;11(2-3):227-9.
1992: K S Sridhar; A M Hussein; Pasquale Benedetto; Bach Ardalan; Niramol Savaraj; Stephen Richman
Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma.
Cancer 1992;70(6):1591-7.
1992: Bach Ardalan; K Stridhar; R Reddy; Pasquale Benedetto; Stephen Richman; S Waldman; L Morrell; Lynn Feun; Niramol Savaraj; Alan Livingstone
Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
International journal of radiation oncology, biology, physics 1992;22(3):511-4.
1992: Rasim Gucalp; P Ritch; Peter H Wiernik; P R Sarma; A Keller; Stephen Richman; K Tauer; J Neidhart; L E Mallette; R Siegel
Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):134-42.
1991: K S Sridhar; William A Raub; Robert Duncan; S Hilsenbeck; Stephen Richman
Lung carcinoma in 1,336 patients.
American journal of clinical oncology 1991;14(6):496-508.
1991: Bach Ardalan; K S Sridhar; Pasquale Benedetto; Stephen Richman; S Waldman; L Morrell; Lynn Feun; Niramol Savaraj; M Fodor; Alan Livingstone
A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
Cancer 1991;68(6):1242-6.
1991: K S Sridhar; A M Hussein; Pasquale Benedetto; S M Waldman; Lynn Feun; Niramol Savaraj; Stephen Richman; Bach Ardalan; P Desai
Phase II trial of mitoxantrone in head and neck carcinoma.
American journal of clinical oncology 1991;14(4):298-304.
1991: Bach Ardalan; Lucy Chua; E M Tian; R Reddy; K Sridhar; Pasquale Benedetto; Stephen Richman; A Legaspi; S Waldman; L Morrell
A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):625-30.
1991: L M Morrell; Bach Ardalan; Stephen Richman; P Goodman; T R Fleming; J S MacDonald
A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group study.
Cancer 1991;67(2):363-6.
1991: Lynn Feun; Niramol Savaraj; Pasquale Benedetto; J Hanlon; K S Sridhar; M Collier; Stephen Richman; S H Liao; N J Clendeninn
Phase I trial of piritrexim capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies.
Journal of the National Cancer Institute 1991;83(1):51-5.
1990: K S Sridhar; T S Samy; Ram P Agarwal; Robert Duncan; Pasquale Benedetto; AWTAR KRISHAN; Charles L Vogel; Lynn Feun; Niramol Savaraj; Stephen Richman
A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokinetics.
Cancer 1990;66(10):2082-91.
1990: K S Sridhar; M J Bounassi; William A Raub; Stephen Richman
Clinical features of adenosquamous lung carcinoma in 127 patients.
The American review of respiratory disease 1990;142(1):19-23.
1988: M S Blumenreich; T M Woodcock; E J Sherrill; Stephen Richman; P S Gentile; B E Epremian; T T Kubota; J C Allegra
A phase I trial of chlorambucil administered in short pulses in patients with advanced malignancies.
Cancer investigation 1988;6(4):371-5.
1987: M S Blumenreich; T M Woodcock; P S Gentile; G R Barnes; B Jose; E J Sherrill; Stephen Richman; B E Epremian; T T Kubota; J C Allegra
High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(11):1725-30.
1986: J Seeger; Stephen Richman; J C Allegra
Systemic therapy of malignant melanoma.
The Medical clinics of North America 1986;70(1):89-94.
1985: M S Blumenreich; T M Woodcock; Stephen Richman; M K Jones; P S Gentile; T T Kubota; J C Allegra
A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies.
Cancer 1985;56(2):256-8.
1985: M S Blumenreich; T M Woodcock; M Jones; Stephen Richman; P S Gentile; T T Kubota; J C Allegra
High-dose cisplatin in patients with advanced malignancies.
Cancer 1985;55(5):1118-22.
1984: T M Woodcock; J C Allegra; Stephen Richman; K Lalley; T T Kubota; M S Blumenreich; P Gentile; M Jones; J Seeger
Pharmacology and phase I clinical studies of daunorubicin in patients with advanced malignancies.
Seminars in oncology 1984;11(4 Suppl 3):28-32.
1984: Stephen Richman; T M Woodcock; T T Kubota; M S Blumenreich; P S Gentile; J C Allegra
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Cancer treatment reports 1984;68(11):1395-6.
1983: T M Woodcock; M S Blumenreich; Stephen Richman; T T Kubota; P S Gentile; J C Allegra
Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(4):247-50.
1982: Lynn Feun; J Gutterman; M A Burgess; Evan M Hersh; G Mavligit; C M McBride; Robert S Benjamin; Stephen Richman; WK Murphy; Gerald P Bodey; B W Brown; C F Mountain; M E Leavens; E J Freireich
The natural history of resectable metastatic melanoma (Stage IVA melanoma).
Cancer 1982;50(8):1656-63.
1982: J C Allegra; T M Woodcock; Stephen Richman; K I Bland; J L Wittliff
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.
Breast cancer research and treatment 1982;2(1):93-9.
1981: Manuel Valdivieso; Stephen Richman; A M Burgess; Gerald P Bodey; E J Freireich
Initial clinical studies of vindesine.
Cancer treatment reports 1981;65(9-10):873-5.
1981: Stephen Richman; Evan M Hersh; J U Gutterman; G N Hortobagyi; G R Blumenschein; A Rios; E Ribi
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effects.
Cancer treatment reports 1981;65(5-6):383-7.
1980: Stephen Richman; J U Gutterman; Evan M Hersh
Chemotherapy and immunotherapy for malignant melanoma.
Comprehensive therapy 1980;6(10):57-61.
1980: G R Blumenschein; G N Hortobagyi; Stephen Richman; J U Gutterman; C K Tashima; A U Buzdar; M A Burgess; R B Livingston; Evan M Hersh
Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.
Cancer 1980;45(4):742-9.
1980: Stephen Richman; V T Chism; S G Murphy
Effect of microbial fractions and vehicle on survival of mice bearing Lewis lung carcinoma.
Cancer treatment reports 1980;64(12):1329-33.
1979: J A Maroun; J R Quesada; Evan M Hersh; J U Gutterman; Stephen Richman; M A Schwarz; N Parker
Phase I toxicity study of methanol-extracted residue of Bacillus Calmette-Guérin by the iv route.
Cancer treatment reports 1979;63(11-12):1781-6.
1979: G N Hortobagyi; J U Gutterman; G R Blumenschein; C K Tashima; M A Burgess; L Einhorn; A U Buzdar; Stephen Richman; Evan M Hersh
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Cancer 1979;44(5):1955-62.
1979: G N Hortobagyi; J U Gutterman; G R Blumenschein; C K Tashima; M A Burgess; L Einhorn; A U Buzdar; Stephen Richman; Evan M Hersh
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Cancer 1979;43(4):1225-33.
1979: Stephen Richman; J U Gutterman; Evan M Hersh
Cancer immunotherapy.
Canadian Medical Association journal 1979;120(3):322-4, 329.
1978: G N Hortobagyi; Stephen Richman; K Dandridge; J U Gutterman; G R Blumenschein; Evan M Hersh
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effects.
Cancer 1978;42(5):2293-303.
1978: B F Issell; Manuel Valdivieso; Evan M Hersh; Stephen Richman; J U Gutterman; Gerald P Bodey
Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Cancer treatment reports 1978;62(7):1059-63.
1978: J U Gutterman; Stephen Richman; C M McBride; M A Burgess; S L Bartold; A Kennedy; E A Gehan; G Mavligit; Evan M Hersh
Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1978;68():359-62.
1977: J Y Suen; Stephen Richman; R B Livingston; Evan M Hersh; R Craig; K Tonymon
Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
American journal of surgery 1977;134(4):474-8.
1977: M A Schwarz; J U Gutterman; Evan M Hersh; Stephen Richman; G M Mavligit
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
World journal of surgery 1977;1(5):555-83.
1977: Stephen Richman; J U Gutterman; Evan M Hersh; M A Burgess; G M Mavligit
Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-Guérin.
Cancer treatment reports 1977;61(3):471-2.
1977: V Rodriguez; Stephen Richman; R S Benjamin; M A Burgess; W K Murphy; Manuel Valdivieso; R L Banner; J U Gutterman; Gerald P Bodey; E J Freireich
Phase 2 study with Baker's Antifol in solid tumors.
Cancer research 1977;37(4):980-3.
1977: G N Hortobagyi; J U Gutterman; G R Blumenschein; A Buzdar; M A Burgess; Stephen Richman; C K Tashima; M Schwarz; Evan M Hersh
Chemo immunotherapy of advanced breast cancer with BCG.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1977;(62):143-50.
1976: Stephen Richman; R B Livingston; J U Gutterman; J Y Suen; Evan M Hersh
Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study.
Cancer treatment reports 1976;60(5):535-9.
1975: Stephen Richman; G M Mavligit; R Wolk; J U Gutterman; Evan M Hersh
Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.
JAMA : the journal of the American Medical Association 1975;234(12):1233-5.
1975: F G Gercovich; Stephen Richman; V Rodriguez; M Luna; K B McCredie; Gerald P Bodey
Successful control of systemic Aspergillus niger infections in two patients with acute leukemia.
Cancer 1975;36(6):2271-6.
1975: J U Gutterman; G Mavligit; R Reed; Stephen Richman; C E McBride; Evan M Hersh
Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
Seminars in oncology 1975;2(2):155-74.
1970: A K Izumi; Stephen Richman
Ectopic adrenocorticotropic hormone syndrome associated with metastatic skin tumors and Cushing's syndrome.
Archives of dermatology 1970;102(5):556-9.
1967: Stephen Richman; C Richman; M R Raju; B Schwartz
Studies on Vicia faba root meristems irradiated with a pion beam.
Radiation research. Supplement 1967;7():182-9.